Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Ret expression and its correlation with clinicopathologic data in papillary thyroid carcinoma (CROSBI ID 277771)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Punda, Ante ; Bedeković, Vladimir ; Barić, Ana ; Kontić, Mirko ; Čolović, Zaviša ; Vanjaka Rogošić, Lucija ; Punda, Hrvoje ; Kunac, Nenad ; Grandić, Leo ; Pešutić Pisac, Valdi Ret expression and its correlation with clinicopathologic data in papillary thyroid carcinoma // Acta clinica Croatica, 57 (2018), 4; 646-652

Podaci o odgovornosti

Punda, Ante ; Bedeković, Vladimir ; Barić, Ana ; Kontić, Mirko ; Čolović, Zaviša ; Vanjaka Rogošić, Lucija ; Punda, Hrvoje ; Kunac, Nenad ; Grandić, Leo ; Pešutić Pisac, Valdi

engleski

Ret expression and its correlation with clinicopathologic data in papillary thyroid carcinoma

The purpose of this study was to analyze the possible prognostic value of RET mutation in papillary thyroid carcinoma and its incidence in the past few decades in our population, due to the increasing incidence of papillary thyroid carcinoma. The present study included 180 patients operated for papillary thyroid carcinoma. The clinical and histopathologic characteristics were analyzed. Paraffin sections of the selected histologic slides were cut again and immunohistochemically stained by the Clone 3F8 P (HIER) from Novocastra (Vision Bio Systems Europe, Newcastle upon Tyne, UK) monoclonal antibody to RET oncoprotein. Univariate analysis indicated sex (p=0.01), histologic subtype (p=0.075) and capsular invasion (p=0.010) to be statistically significant predictors of lymph node metastases, whereas age (p=0.796), tumor size (p=0.556) and intraglandular dissemination (p=0.131) showed no such correlation. The presence of RET mutation (p=0.704) was not a statistically significant predictor of the tumor metastasizing potential. RET mutation (p=0.500) showed no statistically significant correlation with papillary thyroid carcinoma classifed into prognostic groups according to clinicopathologic features either. RET mutation was detected in 30% of 180 papillary thyroid carcinomas. This is the first large study demonstrating that RET mutation incidence in papillary thyroid carcinoma in Croatian population is consistent with the classic distribution of sporadic cases, despite the increased prevalence of papillary thyroid carcinoma in the past few decades.

RET expression ; papillary thyroid carcinoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

57 (4)

2018.

646-652

objavljeno

0353-9466

1333-9451

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost